Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $212.5300 $0.60 0.283%
Day's High: $211.99 Week Perf: -1.46 %
Day's Low: $ 211.26 30 Day Perf: -7.46 %
Volume (M): 4 52 Wk High: $ 263.13
Volume (M$): $ 815 52 Wk Avg: $233.18
Open: $214.84 52 Wk Low: $200.32

 Market Capitalization (Millions $) 18,932
 Shares Outstanding (Millions) 89
 Employees 75,500
 Revenues (TTM) (Millions $) 14,755
 Net Income (TTM) (Millions $) 1,002
 Cash Flow (TTM) (Millions $) -1,195
 Capital Exp. (TTM) (Millions $) 22

Laboratory Corporation Of America Holdings
Laboratory Corporation of America Holdings and its subsidiaries, headquartered in Burlington, North Carolina, is the second largest independent clinical laboratory company in the United States.'Through a national network of laboratories, the Company offers more than 4,400 different clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.'In addition, the Company has developed specialty and niche businesses based on certain types of specialized testing capabilities and client requirements, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical research trials.'The Company has significantly expanded its routine and specialty testing businesses through the acquisitions of Dynacare Inc. ("Dynacare") and DIANON Systems, Inc. ("DIANON").

   Company Address: 358 South Main Street Burlington, 27215 NC
   Company Phone Number: 229-1127   Stock Exchange / Ticker: NYSE LH
   LH is expected to report next financial results on July 31, 2023.

Customers Net Income fell by LH's Customers Net Profit Margin fell to

-2.03 %

2.39 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
DGX        1.19% 
NEO   -3.47%    
• View Complete Report

Taihe Group Inc

The rising entity from the Medical Laboratories market the TIHE reported the financial period ending first quarter of 2023, numbers

As the earnings cycle of fiscal January to March 31 2023 resumes, the most entities have reported their results. In the thick of it, are various entities in the Medical Laboratories industry. As well as, today, TIHE issued operating loss of $-0.019187 million, for the most recent fiscal period.

Data Knights Acquisition Corp

Between many businesses, the DKDCU issued as well its first quarter of 2023 numbers

Centogene N V

A deficit of $-1.33 per Share at the Centogene N V in October to December 31 2022 interval

For the October to December 31 2022 interval CNTG lost money of $-1.33 per share compare to $-2.31 a year ago and from $0.00 per share from the previous financial reporting period. The revenue went down sharply by -75.004 % to $53.17 million from $212.71 million in the same financial reporting period a year ago and sequentially from $0.00 million.

Fresh2 Group Ltd

A loss of $-0.39 per Share at the company in fourth quarter of 2022

Fresh2 Group Ltd reported disappointing October to December 31 2022, where Revenue melted down by -38.129 % to $1.75 million and the Medical Laboratories company recorded net loss per share to $-0.39, compared to $-1.37, in the comparable interval a year before.

Opgen Inc

Very impressive 94.455%, jump in revenue at OPGN all along the first quarter of 2023

As a human, it seems that Opgen Inc, a precision medicine company focused on infectious diseases, has had a challenging fiscal first quarter of 2023. The company reported an increase in the deficit per share, going from $-0.15 to $-1.25 per share compared to the same time last year. Additionally, the deficit per share increased from $-0.23 in the prior quarter.
Despite these financial challenges, Opgen Inc saw a notable increase in revenue. The company's revenue grew by an impressive 94.455% to $0.91 million from $0.47 million in the corresponding quarter a year ago. Sequentially, Opgen Inc had an improvement in revenue of 26.581% from $0.72 million.


Laboratory Of America Holdings's Segments
Routine Testing
 Segment     of total Revenue
Genomic and Esoteric Testing
 Segment     of total Revenue
• View Complete Report

Laboratory Of America Holdings's Operating Statistics Decrease / Increase
Routine Testing Number of Requisitions (millions)   Routine Testing Number of Requisitions (millions) Decline   
Genomic and Esoteric Testing Number of Requisitions (millions)   Genomic and Esoteric Testing Number of Requisitions (millions) Decline   
Ontario Canada Number of Requisitions (millions)   Ontario Canada Number of Requisitions (millions) Decline   
Total Number of Requisitions (millions)   Total Number of Requisitions (millions) Decline   
Routine Testing Revenue Per Requisition ($)   Routine Testing Revenue Per Requisition ($) Decline   
Genomic and Esoteric Testing Revenue Per Requisition ($)     
Ontario Canada Revenue Per Requisition ($)   Ontario Canada Revenue Per Requisition ($) Decline   
Total Revenue Per Requisition ($)   Total  Revenue Per Requisition ($) Decline   


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071